Feedback / Questions
[225Ac]Ac-A9-3408 - Alpha-9 Oncology
https://www.prnewswire.com/news-releases/alpha-9-oncology-announces-first-patient-dosed-in-phase-1-study-of-a9-3408-for-the-treatment-of-melanoma-302632371.html
Dec 4, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next